The Airway Dentistry Sales Funnel: Why Uncontrolled Studies Mislead Parents.
If your child has been diagnosed with obstructive sleep apnea (OSA) or other breathing problems during sleep, you may have heard about rapid palatal expansion (RPE), also called rapid maxillary expansion. This orthodontic treatment uses a device attached to the upper teeth to gradually widen the roof of the mouth, with the goal of opening the nasal passages and improving breathing. The idea sounds logical: a wider palate means more room for air to flow. But does the science support this approach? As a pediatric ENT serving the Frisco, Prosper, and McKinney communities, I understand parents can be flooded with information when making decisions about your child’s health. You deserve to know what the research actually shows.
What the Studies Show: A Tale of Two Types of Evidence
When you search online for information about RPE for sleep apnea, you’ll find many encouraging reports. The most frequently cited research comes from studies that followed children before and after RPE treatment, without comparing them to children who didn’t receive treatment. A 2017 analysis combined 17 such studies involving 314 children and found that their apnea-hypopnea index (AHI, a measure of how many times per hour breathing stops or becomes shallow during sleep) dropped by about 70%, from 8.9 to 2.7 events per hour. Oxygen levels also improved significantly. These numbers look impressive, and they’ve led many parents and practitioners to believe RPE is highly effective.
While many North Dallas dental practices promote RPE as a primary solution, there’s a critical problem with these studies: they don’t account for the fact that many children’s sleep apnea improves on its own as they grow. Young children’s adenoids and tonsils naturally shrink as they get older, and their airways naturally get larger. Without comparing RPE to simply watching and waiting, it’s impossible to know how much of the improvement is due to the treatment versus natural growth.
The Gold Standard: Controlled Studies Paint a Different Picture
The most reliable medical evidence comes from randomized controlled trials, where some children receive treatment and others don’t, allowing researchers to see the true effect of the intervention. When we look at this higher-quality evidence for RPE, the results are far less encouraging.
A 2022 systematic review specifically searched for studies comparing RPE to watchful waiting and found only one randomized trial. That study showed no statistically significant difference in sleep apnea outcomes between children who received RPE and those who simply waited. In other words, the children who got RPE didn’t do any better than those who didn’t.
Even more telling is a 2023 network meta-analysis that pooled data from 11 studies involving 595 children. This analysis found that RPE alone was not associated with any significant reduction in sleep apnea severity compared to doing nothing—the average difference was essentially zero. In contrast, other treatments showed clear benefits: mandibular advancement appliances (devices that move the lower jaw forward) reduced the AHI by 2.18 events per hour, and combining RPE with tonsil and adenoid removal reduced it by 5.13 events per hour.
A recent 2025 randomized trial directly compared RPE to adenotonsillectomy (tonsil and adenoid removal) in 24 children who had both enlarged tonsils/adenoids and a narrow palate. While both treatments improved sleep study numbers, adenotonsillectomy provided significantly better improvement in actual symptoms and quality of life as measured by parent questionnaires. Another randomized crossover study in 32 children found that most of the improvement in sleep apnea was attributable to adenotonsillectomy, with RPE adding only a marginal benefit.
Why the Disconnect? Understanding Natural Growth
Recent research helps explain why uncontrolled studies show such dramatic improvements while controlled studies don’t. A 2024 study that followed children for 12 months after RPE found that much of the airway volume increase—particularly in younger children aged 6-9 years—was due to natural shrinkage of adenoid and tonsil tissue rather than the expansion itself. The researchers concluded that “clinicians should not expect changes in the airways dimensions to be solely related to treatment effects of RPE; instead, normal craniofacial growth changes and spontaneous regression of the adenotonsillar tissue could represent the most significant factors.”
This is crucial information for parents: your child’s breathing may improve over time regardless of whether they undergo RPE, simply because they’re growing and their adenoids are naturally shrinking.
What Do National Medical Guidelines Say?
You might expect that if RPE were an established treatment for pediatric sleep apnea, major medical organizations would include it in their guidelines. They don’t. The American Academy of Pediatrics (AAP), the American Academy of Otolaryngology–Head and Neck Surgery (the ENT doctors’ organization), the American Academy of Sleep Medicine, and the European Respiratory Society have no official position on RPE for pediatric sleep apnea. None of these organizations include RPE in their treatment guidelines.
The one exception is the American Thoracic Society (ATS), which published guidelines in 2024 specifically addressing children who still have sleep apnea after tonsil and adenoid removal. The ATS issued what they call a “conditional recommendation”—meaning the evidence is weak and the decision depends heavily on individual circumstances—suggesting that RPE may be considered for children with persistent sleep apnea after surgery who have a clearly narrow, high-arched palate (often with a posterior crossbite, where the back teeth don’t line up properly). The ATS explicitly states this recommendation is based on “very low certainty evidence.”
The ATS guidelines specify that RPE is typically best performed between ages 6 and 13, before the bones of the palate fuse together. They estimate an average improvement of about 3.3 events per hour in the AHI and a 2.8% increase in oxygen saturation—modest improvements in a very specific population. Importantly, the guidelines note that there are no published studies on whether RPE is cost-effective for sleep apnea, and that medical insurance in the United States usually won’t cover the procedure.
The Financial Reality
This brings us to an important practical consideration: cost. RPE typically costs between $2,000 and $4,000 out of pocket, as most medical insurance plans don’t cover it for sleep apnea treatment (they consider it a dental/orthodontic procedure). Some dental insurance plans may provide partial coverage, but parents should expect to pay most or all of the cost themselves. Given that the highest-quality evidence shows no significant benefit over watchful waiting, this is a substantial investment for uncertain returns.
What About Side Effects and Long-Term Results?
While RPE is generally considered safe, it’s not without side effects. Studies have reported that children may experience difficulties with tongue mobility, trouble protruding the tongue toward the nose, difficulty holding objects between the lips, and occasionally trouble swallowing liquids. These effects are usually temporary but can be bothersome during treatment.
The long-term durability of any airway improvements is also uncertain. Research suggests that improvements in nasal breathing may be stable for about 11 months, but there’s potential for relapse after that. This means your child may need repeat sleep studies to monitor whether the benefits persist, and some children may need additional treatment down the line.
So What Should Parents Do?
Based on the current evidence, here’s what parents should know:
First-line treatment remains tonsil and adenoid removal. If your child has enlarged tonsils and adenoids and has been diagnosed with obstructive sleep apnea, adenotonsillectomy is still the most effective and evidence-based first treatment. This is endorsed by the American Academy of Pediatrics and the American Academy of Otolaryngology.
RPE is not a primary treatment for sleep apnea. The evidence does not support using RPE as the initial treatment for pediatric sleep apnea in any population.
RPE might be considered in one specific situation. If your child still has sleep apnea after tonsil and adenoid removal AND has a clearly narrow, high-arched palate (which your child’s doctor or orthodontist can identify), then RPE may be worth discussing. Even in this scenario, the evidence is very weak, and you should understand that the only randomized trial comparing RPE to watchful waiting showed no significant benefit.
Be prepared for out-of-pocket costs. Budget for $2,000-$4,000 that likely won’t be covered by insurance.
Ask about alternatives. For children with persistent sleep apnea after surgery, other options include weight management (if applicable), positional therapy, CPAP (continuous positive airway pressure), or mandibular advancement devices. Discuss all options with your child’s sleep specialist and ENT doctor.
Beware of overpromising. If a provider tells you that RPE will definitely cure your child’s sleep apnea based on “70% improvement rates,” they’re likely citing uncontrolled studies that don’t account for natural growth. Ask them about the controlled trial evidence and why major medical societies haven’t endorsed RPE for this indication.
The Bottom Line
As a parent, you want the best for your child, and it’s natural to be attracted to treatments that promise to help them breathe better and sleep more soundly. Rapid palatal expansion can successfully widen the palate—that’s not in question. What is in question is whether that widening translates into meaningful, lasting improvements in sleep apnea that wouldn’t have happened anyway through normal growth.
The highest-quality evidence—randomized controlled trials and systematic reviews—shows that RPE alone does not provide significant benefit over watchful waiting for pediatric sleep apnea. The only medical society that includes RPE in its guidelines does so with a conditional recommendation based on very low certainty evidence, limited to a specific subset of children who have already had their tonsils and adenoids removed and have a clearly narrow palate.
This doesn’t mean RPE is never appropriate. For the right child in the right circumstances—particularly those with persistent sleep apnea after surgery and clear maxillary constriction—it may be worth considering as part of a comprehensive treatment plan. But it should be approached with realistic expectations, full awareness of the limited evidence, understanding of the out-of-pocket costs, and close collaboration between your child’s orthodontist, sleep specialist, and ENT doctor.
Your child’s sleep and breathing are too important for decisions based on wishful thinking or marketing. Demand evidence, ask hard questions, and make sure any treatment plan is based on your child’s specific anatomy and circumstances rather than one-size-fits-all enthusiasm for a procedure that the science hasn’t yet proven effective.